Taken together, these lines of evidence convincingly support our conclusion that LSM12 and EPAC1 constitute a neuroprotective pathway for sustaining the RAN gradient and NCT in the pathophysiology of C9ORF72-associated ALS/FTD. This evidence concerns the gene LSM12 and amyotrophic lateral sclerosis.